BioStem Technologies (BioStem Technologies) FCF Margin % : 0.00% (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. BioStem Technologies's Free Cash Flow for the three months ended in Sep. 2023 was $0.00 Mil. BioStem Technologies's Revenue for the three months ended in Sep. 2023 was $3.60 Mil. Therefore, BioStem Technologies's FCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

As of today, BioStem Technologies's current FCF Yield % is -0.73%.

The historical rank and industry rank for BioStem Technologies's FCF Margin % or its related term are showing as below:

BSEM' s FCF Margin % Range Over the Past 10 Years
Min: -1880 Med: -377.11 Max: -3.5
Current: -16.69

During the past 13 years, the highest FCF Margin % of BioStem Technologies was -3.50%. The lowest was -1880.00%. And the median was -377.11%.

BSEM's FCF Margin % is ranked better than
70.96% of 1047 companies
in the Biotechnology industry
Industry Median: -145.04 vs BSEM: -16.69

BioStem Technologies FCF Margin % Historical Data

The historical data trend for BioStem Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioStem Technologies FCF Margin % Chart

BioStem Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-379.45

-37.26

-23.08

-3.50

-30.63

BioStem Technologies Quarterly Data
	Sep15	Dec15	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23
FCF Margin %	Get a 7-Day Free Trial															17.27	-	-	-143.92	-

Competitive Comparison of BioStem Technologies's FCF Margin %

For the Biotechnology subindustry, BioStem Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioStem Technologies's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioStem Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where BioStem Technologies's FCF Margin % falls into.

BioStem Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

BioStem Technologies's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-2.106	/	6.875
	=	-30.63 %

BioStem Technologies's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	0	/	3.599
	=	0.00 %

BioStem Technologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

BioStem Technologies (BioStem Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2836 Center Port Circle, Pompano Beach, FL, USA, 33064

Website

https://www.biostemtechnologies.com

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.